On Friday, it was reported that the European Union could pay more than $10 billion according to an EU official involved in the talks that would get it hundreds of millions of doses of the vaccines being developed by fires, thereby on tech and Cure Vac.

The source told Reuters that the block has agreed to pay around $18 per dose for the Covid-19 vaccine being developed by Pfizer and Biontech. Pricing Information was previously undisclosed, but the report confirms that the EU would be paying less per dose than the United States for an initial supply of that vaccine.

The source added that the deal includes an insurance for EU countries to get compensation if the company's divert doses to the U.

S.

In a separate deal.

The officials said that the EU has agreed to pay a little under $12 per dose for an initial supply of 225 million doses of the vaccine candidate from Cure Vac.

This week, the block struck a deal with the firm to secure the supply of up to 405 million doses, with deliveries reportedly starting by the end of March.

A spokesman for the European Commission, the Blocks executive body, declined to comment on terms and pricing.

Germany's by on Tech and Cure Vac also declined to comment.

US drugmaker Pfizer said it and biotech were using a tiered pricing formula based on volume and delivery dates.

It said the EU deal represented the largest initial order off its vaccine candidate to date.

Fighter and Biotech said on Wednesday that final data showed their shot was 95% effective against covert 19.